Kidney Selective Bcl2 Inhibitor Delivery Improves Fibrosis Treatment
ACS Applied Bio Materials · 02.06.2026
DOI: 10.1021/acsabm.6c00062 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 02.06.2026. Verfasst von Humayra Afrin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, School of Pharmacy, University of Texas at El Paso, El Paso, Texas 79902, United States. Hauptthemen laut MEDLINE: Fibrosis, Proto-Oncogene Proteins c-bcl-2, Kidney, Biocompatible Materials. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, School of Pharmacy, University of Texas at El Paso, El Paso, Texas 79902, United States.
- Division of Nephrology and Hypertension, Mayo Clinic Rochester, Minnesota 55904, United States.
- Department of Chemistry and Biochemistry, College of Sciences, University of Texas at El Paso, El Paso, Texas 79968, United States.
- Department of Biomedical Engineering, Institute for Quantitative Health Science and Engineering, Michigan State University, East Lansing, Michigan 48824, United States.
- Department of Chemical and Biological Engineering, Korea National University of Transportation, Chungju 27469, Republic of Korea.
ORCID-Profile: Humayra Afrin, Md Nurul Huda, Taeho Kim, Md Nurunnabi
Förderung
- National Research Foundation of Korea
Zitieren
APA
Afrin, H., Chakraborty, S., Nafiujjaman, M., Huda, M. N., Kim, T., Vukovic, L., Lee, Y. K., & Nurunnabi, M. (2026). Kidney Selective Bcl2 Inhibitor Delivery Improves Fibrosis Treatment. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.6c00062
Vancouver
Afrin H, Chakraborty S, Nafiujjaman M, Huda MN, Kim T, Vukovic L, et al. Kidney Selective Bcl2 Inhibitor Delivery Improves Fibrosis Treatment. ACS Applied Bio Materials. 2026. doi:10.1021/acsabm.6c00062
BibTeX
@article{Afrin2026,
author = {Afrin, Humayra and Chakraborty, Sayantani and Nafiujjaman, Md and Huda, Md Nurul and Kim, Taeho and Vukovic, Lela and Lee, Yong-Kyu and Nurunnabi, Md},
title = {Kidney Selective Bcl2 Inhibitor Delivery Improves Fibrosis Treatment},
journal = {ACS Applied Bio Materials},
year = {2026},
doi = {10.1021/acsabm.6c00062}
}
EUVIMED